A method for measuring polarized protein sorting at the blood-brain barrier in vivo is established and a change in membrane protein distribution that aligns with circadian rhythms is observed, revealing an under-appreciated dimension of BBB dynamics.
Abstract
The blood-brain barrier (BBB), formed by brain endothelial cells (BECs), creates a safe and homeostatic environment for proper brain function. Together with pericytes and astrocytes, the BBB controls substance influx and efflux into and out of the brain. While BECs are extraordinarily thin, their luminal and abluminal plasma membranes face markedly different environments: the blood and brain parenchyma, respectively. How BBB membrane proteins are spatially distributed between these membranes and the factors regulating their localization are not clear. Here, we establish a method for measuring polarized protein sorting at the BBB in vivo. We characterize the distribution of transporters and receptors on the luminal and abluminal plasma membranes and identify protein-intrinsic motifs that control polarized sorting. Finally, we observe a change in membrane protein distribution that aligns with circadian rhythms, revealing an under-appreciated dimension of BBB dynamics. This method can be broadly used for evaluating membrane protein landscape changes during development and disease and for choosing optimal molecular targets for BBB-crossing therapeutics.
This review examines the molecular and cellular organization of the BBB and explores how defective cell adhesion and signaling networks lead to BBB pathologies, and synthesizes current knowledge of BBB biology with particular emphasis on recent discoveries in signaling pathways, intercellular adhesion, and dynamic regu...
Joseph H. McCarty· Arteriosclerosis, Thrombosis...· 0 citations
The blood-brain barrier (BBB) is a specialized interface that tightly regulates the exchange of molecules between the bloodstream and the brain. Its barrier function relies on a monolayer of brain endothelial cells sealed by tight junctions (TJs) that restrict paracellular flux through claudin-5 (CLDN5) multimeric comp...
Alessandro Berselli, Martina Trevisani, Giulio Alberini et al.· bioRxiv· 0 citations
It is proposed that next-generation CNS nanomedicines should be designed by considering therapeutic action at luminal, endothelial, and perivascular sites according to the vascular state of disease, rather than being guided solely by parenchymal delivery.
Ebrahim Sadaqa, A. Hanafy· Journal of Controlled Releas...· 0 citations
The blood–brain barrier (BBB) is a highly selective membrane that restricts the delivery of therapeutics into the brain. In this review, we consider a number of computational techniques that can be used to assess BBB transport and central nervous system (CNS) delivery. We outline the details of human brain microvascula...
J. Oluwasegun, Ben William Franey, Christian Jorgensen· Membranes· 0 citations
Novel insights are provided into Aβ-associated molecular alterations in brain microvascular membrane proteins and understanding of BBB changes in AD is advanced, supporting the development of BBB-targeted therapeutic approaches and strategies for optimizing brain drug delivery in AD.
Jooseppi Hyvärinen, Rositsa Todorovska, Maria del Pilar Palacios et al.· Molecular Pharmaceutics· 0 citations
Brain endothelial cells (BECs) are specialized components of the neurovascular unit that couple circulating signals to cerebral blood flow regulation, blood–brain barrier (BBB) function, and selective molecular transport. This narrative review evaluates the correlation of these endothelial functions with psychiatric di...
Meng-Jie Zhang, Xue-Ying Huang, Lin Yao et al.· Frontiers in Cellular Neuros...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.